Esperion Therapeutics Inc (ESPR)

30.30
4.10 16.00
NASDAQ : Health Care
Prev Close 26.17
Open 26.86
Day Low/High 26.75 / 30.53
52 Wk Low/High 9.58 / 98.56
Volume 1.50M
Avg Volume 579.70K
Exchange NASDAQ
Shares Outstanding 22.56M
Market Cap 583.51M
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of April 21st Options Trading For Esperion Therapeutics

First Week of April 21st Options Trading For Esperion Therapeutics

Investors in Esperion Therapeutics Inc saw new options become available this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ESPR options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Esperion Therapeutics Reaches Analyst Target Price

Esperion Therapeutics Reaches Analyst Target Price

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $17.10, changing hands for $17.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Premarket Biotech Movers: Portola, Esperion, Medicines

Premarket Biotech Movers: Portola, Esperion, Medicines

Portola Pharmaceuticals, Esperion Therapeutics and Medicines were among the biotech stock movers in premarket trading on Friday.

Notable Two Hundred Day Moving Average Cross - ESPR

Notable Two Hundred Day Moving Average Cross - ESPR

In trading on Wednesday, shares of Esperion Therapeutics Inc crossed below their 200 day moving average of $13.34, changing hands as low as $13.03 per share. Esperion Therapeutics Inc shares are currently trading off about 4.9% on the day.

Commit To Buy Esperion Therapeutics At $11, Earn 24.7% Annualized Using Options

Commit To Buy Esperion Therapeutics At $11, Earn 24.7% Annualized Using Options

Investors eyeing a purchase of Esperion Therapeutics Inc shares, but tentative about paying the going market price of $13.56/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $11 strike, which has a bid at the time of this writing of $1.20.

Esperion To Present At The 35th Annual J.P. Morgan Healthcare Conference

Esperion To Present At The 35th Annual J.P. Morgan Healthcare Conference

Presentation and Webcast on Tuesday, January 10, 2017 at 3:00 p.m. Pacific Time/6:00 p.m. Eastern Time

Bullish Two Hundred Day Moving Average Cross - ESPR

Bullish Two Hundred Day Moving Average Cross - ESPR

In trading on Monday, shares of Esperion Therapeutics Inc crossed above their 200 day moving average of $13.53, changing hands as high as $13.85 per share. Esperion Therapeutics Inc shares are currently trading up about 5.9% on the day.

ESPR: Insiders vs. Shorts

ESPR: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/15/2016 settlement date, and Esperion Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 8.69 "days to cover" versus the median component at 4.41. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

7 Unusual-Volume Stocks That Are About to Break Out

7 Unusual-Volume Stocks That Are About to Break Out

These stocks rising on unusual volume are within range of triggering big breakout trades.

ESPR: Insiders vs. Shorts

ESPR: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/15/2016 settlement date, and Esperion Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 9.69 "days to cover" versus the median component at 5.83. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

It's Time to Bring the Heat

It's Time to Bring the Heat

I'm starting a new periodic feature that will bring you the hottest-trading stocks I see.

These 5 Stocks Are Breaking Out

These 5 Stocks Are Breaking Out

Here's a technical look at how to trade five stocks that look poised to break out and trade higher from current levels.

Commit To Purchase Esperion Therapeutics At $8, Earn 28.2% Annualized Using Options

Commit To Purchase Esperion Therapeutics At $8, Earn 28.2% Annualized Using Options

Investors considering a purchase of Esperion Therapeutics Inc shares, but cautious about paying the going market price of $10.50/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $8 strike, which has a bid at the time of this writing of $1.00.

Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill

Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill

Esperion Therapeutics and the U.S. Food and Drug Administration failed to reach agreement on a definitive approval path for the company's cholesterol-lowering pill.

ESPR: Insiders vs. Shorts

ESPR: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Esperion Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 10.33 "days to cover" versus the median component at 5.75. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.